Skip to main content
Log in

MASLD/NAFLD: research and clinical innovations

Participating journal: BMC Gastroenterology
This collection seeks to compile the latest research findings and clinical insights within the domain of MASLD. The increasing prevalence of MASLD worldwide is placing a substantial burden on healthcare systems and public health resources. While MASLD encompasses a spectrum of liver conditions, from simple steatosis to metabolic dysfunction-associated steatohepatitis (MASH) and cirrhosis, its potential progression remains a serious concern for overall health.

Participating journal

Submit your manuscript to this collection through the participating journal.

BMC Gastroenterology is an open access, peer-reviewed journal that considers articles on all aspects of the prevention, diagnosis and management of gastrointestinal and hepatobiliary...

Editors

  • Ludovico Abenavoli

    Ludovico Abenavoli

    Ludovico Abenavoli is associate professor in gastroenterology at the Department of Health Sciences, University “Magna Graecia” of Catanzaro, Italy. He got his medical education at the “Catholic University” of Rome, Italy. From 2005 to 2006, he was fellow at the Liver Unit, University Paris VI, France. In 2011, he was invited researcher in the Liver Unit, Hôpital Jean Verdier, University Paris XIII, France. From 2012 to 2014, he was invited professor at the University of Batna, Algeria.
  • Yang Zou

    Yang Zou

    Zou Yang currently works at Jiangxi Provincial People's Hospital, China. His research focuses on the role of lipid metabolism in the development/reversal of NAFLD/MASLD.

Articles

Showing 1-8 of 8 articles

Navigation